Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Breast Neoplasms 19Lung Neoplasms 11Stomach Neoplasms 9Colorectal Neoplasms 9Pancreatic Neoplasms 8Endometrial Neoplasms 8Ovarian Neoplasms 7Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Prostatic Neoplasms 5Neoplasms 5Neoplasm Metastasis 5Esophageal Neoplasms 5Carcinoma, Renal Cell 4Carcinoma, Hepatocellular 4Breast Neoplasms, Male 4Thyroid Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3Rectal Neoplasms 3Melanoma 3Gallbladder Neoplasms 3Colonic Neoplasms 3Carcinoma, Ovarian Epithelial 3Vulvar Neoplasms 2Vipoma 2Vaginal Neoplasms 2Uterine Neoplasms 2

Interventions

tucatinib 1pembrolizumab 1niraparib 1atezolizumab 1Trastuzumab 1Tissue Banks 1GSK-3326595 1Fulvestrant 1Etoposide 1Diet 1Cyclophosphamide 1Blood Specimen Collection 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Trastuzumab × Thoracic × Clear all
NCT04579380 2025-12-19

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Seagen Inc.

Phase 2 Active not recruiting
217 enrolled 19 charts
BreastGastrointestinalGenitourinaryGynecologicThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Urologic Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡